13 Citations (Scopus)

Abstract

Pediatric cancer survivors have increased risk of obesity, hypertension, dyslipidemia, and type 2 diabetes, leading to premature cardiovascular disease (CVD). Multiple tissues that are involved in glucose homeostasis and lipid metabolism are adversely affected by chemotherapy. This review highlights the relevant tissue and molecular end-organ effects of therapy exposures and synthesizes the current understanding of the mechanisms underlying CVD risk in this vulnerable population. The review also approaches the topic from a developmental perspective, with the goal of providing a translational approach to identifying the antecedents of overt CVD among survivors of pediatric cancer. Pediatr Blood Cancer 2013;60:1922-1928.

Original languageEnglish (US)
Pages (from-to)1922-1928
Number of pages7
JournalPediatric Blood and Cancer
Volume60
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Survivors
Cardiovascular Diseases
Pediatrics
Implosive Therapy
Neoplasms
Vulnerable Populations
Dyslipidemias
Lipid Metabolism
Type 2 Diabetes Mellitus
Homeostasis
Obesity
Hypertension
Glucose
Drug Therapy

Keywords

  • Adolescents
  • Cardiovascular disease
  • Children
  • Metabolic syndrome
  • Pediatric cancer survivor

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Metabolic syndrome in pediatric cancer survivors : A mechanistic review. / Rosen, Galit P.; Nguyen, Hoai Trinh; Shaibi, Gabriel.

In: Pediatric Blood and Cancer, Vol. 60, No. 12, 12.2013, p. 1922-1928.

Research output: Contribution to journalArticle

Rosen, Galit P. ; Nguyen, Hoai Trinh ; Shaibi, Gabriel. / Metabolic syndrome in pediatric cancer survivors : A mechanistic review. In: Pediatric Blood and Cancer. 2013 ; Vol. 60, No. 12. pp. 1922-1928.
@article{a5535298383845db9d3535d98af536d4,
title = "Metabolic syndrome in pediatric cancer survivors: A mechanistic review",
abstract = "Pediatric cancer survivors have increased risk of obesity, hypertension, dyslipidemia, and type 2 diabetes, leading to premature cardiovascular disease (CVD). Multiple tissues that are involved in glucose homeostasis and lipid metabolism are adversely affected by chemotherapy. This review highlights the relevant tissue and molecular end-organ effects of therapy exposures and synthesizes the current understanding of the mechanisms underlying CVD risk in this vulnerable population. The review also approaches the topic from a developmental perspective, with the goal of providing a translational approach to identifying the antecedents of overt CVD among survivors of pediatric cancer. Pediatr Blood Cancer 2013;60:1922-1928.",
keywords = "Adolescents, Cardiovascular disease, Children, Metabolic syndrome, Pediatric cancer survivor",
author = "Rosen, {Galit P.} and Nguyen, {Hoai Trinh} and Gabriel Shaibi",
year = "2013",
month = "12",
doi = "10.1002/pbc.24703",
language = "English (US)",
volume = "60",
pages = "1922--1928",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Metabolic syndrome in pediatric cancer survivors

T2 - A mechanistic review

AU - Rosen, Galit P.

AU - Nguyen, Hoai Trinh

AU - Shaibi, Gabriel

PY - 2013/12

Y1 - 2013/12

N2 - Pediatric cancer survivors have increased risk of obesity, hypertension, dyslipidemia, and type 2 diabetes, leading to premature cardiovascular disease (CVD). Multiple tissues that are involved in glucose homeostasis and lipid metabolism are adversely affected by chemotherapy. This review highlights the relevant tissue and molecular end-organ effects of therapy exposures and synthesizes the current understanding of the mechanisms underlying CVD risk in this vulnerable population. The review also approaches the topic from a developmental perspective, with the goal of providing a translational approach to identifying the antecedents of overt CVD among survivors of pediatric cancer. Pediatr Blood Cancer 2013;60:1922-1928.

AB - Pediatric cancer survivors have increased risk of obesity, hypertension, dyslipidemia, and type 2 diabetes, leading to premature cardiovascular disease (CVD). Multiple tissues that are involved in glucose homeostasis and lipid metabolism are adversely affected by chemotherapy. This review highlights the relevant tissue and molecular end-organ effects of therapy exposures and synthesizes the current understanding of the mechanisms underlying CVD risk in this vulnerable population. The review also approaches the topic from a developmental perspective, with the goal of providing a translational approach to identifying the antecedents of overt CVD among survivors of pediatric cancer. Pediatr Blood Cancer 2013;60:1922-1928.

KW - Adolescents

KW - Cardiovascular disease

KW - Children

KW - Metabolic syndrome

KW - Pediatric cancer survivor

UR - http://www.scopus.com/inward/record.url?scp=84885741038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885741038&partnerID=8YFLogxK

U2 - 10.1002/pbc.24703

DO - 10.1002/pbc.24703

M3 - Article

VL - 60

SP - 1922

EP - 1928

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 12

ER -